Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women


Iversen O., Miranda M. J. , Ulied A., Soerdal T., Lazarus E., Chokephaibulkit K., ...Daha Fazla

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, cilt.316, ss.2411-2421, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 316 Konu: 22
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1001/jama.2016.17615
  • Dergi Adı: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
  • Sayfa Sayıları: ss.2411-2421

Özet

IMPORTANCE Human papillomavirus (HPV) infections cause anogenital cancers and warts. The 9-valent HPV vaccine provides protection against 7 high-risk types of HPV responsible for 90% of cervical cancers and 2 other HPV types accounting for 90% of genital warts.